Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (9): 927-931,936    DOI: 10.19485/j.cnki.issn2096-5087.2025.09.013
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2010—2024年萧山区结直肠癌发病趋势分析
李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段
杭州市萧山区疾病预防控制中心(杭州市萧山区卫生监督所),浙江 杭州 311203
Trend in incidence of colorectal cancer in Xiaoshan District from 2010 to 2024
LI Yurong, WANG Dongfei, GAO Yuanyuan, JIANG Yuanyuan, LIN Junying, XIAO Duanduan
Xiaoshan District Center for Disease Control and Prevention (Xiaoshan District Institute of Public Health Supervision), Hangzhou, Zhejiang 311203, China
全文: PDF(863 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2010—2024年杭州市萧山区结直肠癌发病趋势,并预测2025—2027年结直肠癌发病率,为完善结直肠癌防控策略提供依据。方法 通过杭州市慢性病监测管理系统收集2010—2024年萧山区结直肠癌发病资料,计算结直肠癌粗发病率,采用2010年第六次全国人口普查标准人口年龄构成计算中国人口标化率(中标率),采用Segi's世界标准人口年龄构成计算世界人口标化率(世标率);采用平均年度变化百分比(AAPC)分析2010—2024年结直肠癌发病趋势。建立指数平滑空间状态(TBATS)模型预测2025—2027年结直肠癌粗发病率。结果 2010—2024年萧山区结直肠癌新发病例10 726例,粗发病率、中标率和世标率分别为59.25/10万、38.62/10万和29.50/10万。男性结直肠癌粗发病率、中标率和世标率分别为70.56/10万、44.44/10万和35.58/10万,女性分别为48.37/10万、32.69/10万和23.70/10万;男性结直肠癌中标率高于女性(P<0.05)。2010—2024年男性、女性和全人群结直肠癌粗发病率呈上升趋势(AAPC=4.916%、3.795%和4.442%,均P<0.05)。0~<35岁、35~<50岁、50~<75岁和≥75岁组结直肠癌粗发病率分别为1.75/10万、19.86/10万、112.28/10万和272.99/10万,随年龄增长呈上升趋势(P<0.05);2010—2024年≥75岁组结直肠癌粗发病率呈上升趋势(AAPC=4.470%,P<0.05),其他年龄组无明显变化趋势(均P>0.05)。TBATS模型拟合(预测)良好,预测2025—2027年全人群结直肠癌粗发病率逐年升高,预计2027年达70.45/10万。结论 2010—2024年萧山区结直肠癌粗发病率呈上升趋势,2025—2027年发病率可能持续升高;男性和老年人是结直肠癌防控的重点人群。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李玉荣
王冬飞
高媛媛
蒋园园
林君英
肖段段
关键词 结直肠癌发病率平均年度变化百分比    
AbstractObjective To analyze the incidence trend of colorectal cancer in Xiaoshan District, Hangzhou City from 2010 to 2024, and predict the incidence of colorectal cancer from 2025 to 2027, so as to provide the evidence for improving the prevention and control strategies of colorectal cancer. Methods Colorectal cancer incidence data from 2010 to 2024 in Xiaoshan District were collected through the Hangzhou Municipal Chronic Disease Monitoring Management System. The crude incidence of colorectal cancer was calculated, and standardized using the data from the Sixth National Population Census in 2010 (Chinese standardized rate) and the Segi's world standard population (world standardized rate). The trend of colorectal cancer incidence from 2010 to 2024 was analyzed using the average annual percent change (AAPC). An exponential smoothing state space model with trigonometric seasonality, box-cox transformation, ARMA errors, trend and seasonal components (TBATS) was established to forecast the crude incidence of colorectal cancer from 2025 to 2027. Results There were 10 726 new cases of colorectal cancer in Xiaoshan District from 2010 to 2024. The crude incidence, Chinese standardized rate, and world standardized rate of colorectal cancer were 59.25/105, 38.62/105 and 29.50/105, respectively. The crude incidence, Chinese standardized rate, and world standardized rate of colorectal cancer in males were 70.56/105, 44.44/105 and 35.58/105, respectively, while those in females were 48.37/105, 32.69/105 and 23.70/105, respectively. The Chinese standardized rate of colorectal cancer was significantly higher in males than in females (P<0.05). The crude incidence of colorectal cancer in males, females and the whole population showed upward trends from 2010 to 2024 (AAPC=4.916%, 3.795% and 4.442%, all P<0.05). The crude incidence of colorectal cancer in the groups of 0-<35, 35-<50, 50-<75 and ≥75 years were 1.75/105, 19.86/105, 112.28/105 and 272.99/105, respectively, showing an increasing trend with age (P<0.05). From 2010 to 2024, the crude incidence of colorectal cancer in the ≥75 years group showed an increasing trend (AAPC=4.470%, P<0.05), while no significant trend was observed in other age groups (all P>0.05). TBATS model demonstrated good fitting (predictive) performance, indicating a year-by-year increase in the crude incidence of colorectal cancer across the whole population from 2025 to 2027, with an estimated rate reaching 70.45/105 in 2027. Conclusions The crude incidence of colorectal cancer in Xiaoshan District showed an increasing trend from 2010 to 2024, and it is predicted to continue to increase from 2025 to 2027. Males and the elderly are the key populations for colorectal cancer prevention and control.
Key wordscolorectal cancer    incidence    average annual percent change
收稿日期: 2025-07-03      修回日期: 2025-08-10      出版日期: 2025-09-10
中图分类号:  R735.34  
作者简介: 李玉荣,硕士,主管医师,主要从事慢性病预防与控制工作
通信作者: 蒋园园,E-mail:623986074@qq.com   
引用本文:   
李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
LI Yurong, WANG Dongfei, GAO Yuanyuan, JIANG Yuanyuan, LIN Junying, XIAO Duanduan. Trend in incidence of colorectal cancer in Xiaoshan District from 2010 to 2024. Preventive Medicine, 2025, 37(9): 927-931,936.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.09.013      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I9/927
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] 赫捷,魏文强.2019中国肿瘤登记年报[M].北京:人民卫生出版社,2021.
HE J,WEI W Q.2019 China cancer registry annual report[M].Beijing:People's Medical Publishing House,2021.(in Chinese)
[3] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53.
[4] 朱陈,龚巍巍,钟节鸣,等.浙江省重点人群结直肠癌筛查项目设计和实施方案[J].中国肿瘤,2020,29(12):899-903.
ZHU C,GONG W W,ZHONG J M,et al.Zhejiang Colorectal Cancer Screening Program:overview and study design[J].China Cancer,2020,29(12):899-903.(in Chinese)
[5] 程向东,杜灵彬.2023浙江省肿瘤登记年报[M].北京:清华大学出版社,2024.
CHENG X D,DU L B.Zhejiang cancer registry annual report[M].Beijing:Tsinghua University Press,2024.(in Chinese)
[6] 李玉荣,汪芬娟,王冬飞,等.2015—2020年萧山区恶性肿瘤发病趋势分析[J].预防医学,2023,35(8):687-691.
LI Y R,WANG F J,WANG D F,et al.Trends in incidence of malignant tumors in Xiaoshan District from 2015 to 2020[J].China Prev Med J,2023,35(8):687-691.(in Chinese)
[7] DE LIVERA A M,HYNDMAN R J,SNYDER R D.Forecasting time series with complex seasonal patterns using exponential smoothing[J].J Am Stat Assoc,2011,106(496):1513-1527.
[8] 寻鲁宁,王冲,沈成凤,等.1990—2019年中国结直肠癌发病趋势分析及预测模型比较[J].中国肿瘤,2023,32(4):279-286.
XUN L N,WANG C,SHEN C F,et al.Prediction of colorectal cancer incidence in China with three different models based on trends from 1990 to 2019[J].China Cancer,2023,32(4):279-286.(in Chinese)
[9] 胡碧波,傅克本,邵哲.2015—2021年浙江省余姚市结直肠癌发病死亡情况及生存分析[J].疾病监测,2022,37(9):1230-1235.
HU B B,FU K B,SHAO Z,et al.Morbidity,mortality and survival of colorectal cancer in Yuyao,Zhejiang,2015-2021[J].Dis Surveill,2022,37(9):1230-1235.(in Chinese)
[10] ZHOU J C,ZHENG R S,ZHANG S W,et al.Colorectal cancer burden and trends:comparison between China and major burden countries in the world[J].Chin J Cancer Res,2021,33(1):1-10.
[11] 夏昌发,陈万青.中国恶性肿瘤负担归因于人口老龄化的比例及趋势分析[J].中华肿瘤杂志,2022,44(1):79-85.
XIA C F,CHEN W Q.Fractions and trends of cancer burden attributable to population ageing in China[J].Chin J Oncol,2022,44(1):79-85.(in Chinese)
[12] 毛纯,陈桂芳,盘宇洁,等.1972—2015年广州市城区居民结直肠癌发病率和死亡率趋势分析及预测[J].中华预防医学杂志,2021,55(5):640-645.
MAO C,CHEN G F,PAN Y J,et al.Trend analysis and prediction of colorectal cancer morbidity and mortality of residents in urban areas of Guangzhou from 1972 to 2015[J].Chin J Prev Med,2021,55(5):640-645.(in Chinese)
[13] 赵琳,蒋龙艳,徐斌,等.南宁市五种主要恶性肿瘤发病率分析[J].预防医学,2025,37(2):135-138.
ZHAO L,JIANG L Y,XU B,et al.Incidence characteristics of five major malignant tumors in Nanning City[J].China Prev Med J,2025,37(2):135-138.(in Chinese)
[14] 陈单,王亚伟,黄芳,等.2003—2019年上海市嘉定区结直肠癌流行趋势研究[J].中国全科医学,2024,27(10):1261-1266.
CHEN D,WANG Y W,HUANG F,et al.Epidemic trend analysis of colorectal cancer in Jiading District,Shanghai from 2003 to 2019[J].Chin Gen Pract,2024,27(10):1261-1266.(in Chinese)
[15] ARNOLD M,SIERRA M S,LAVERSANNE M,et al.Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2017,66(4):683-691.
[16] WONG M C S,HUANG J J,LOK V,et al.Differences in incidence and mortality trends of colorectal cancer worldwide based on sex,age,and anatomic location[J].Clin Gastroenterol Hepatol,2021,19(5):955-966.
[17] KIM M H,PARK S,YI N Y,et al.Colorectal cancer mortality trends in the era of cancer survivorship in Korea:2000-2020[J].Ann Coloproctol,2022,38(5):343-352.
[18] 陈淑淑,龚巍巍,关云琦,等.1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J].预防医学,2024,36(3):203-206.
CHEN S S,GONG W W,GUAN Y Q,et al.Disease burden and risk factors of colorectal cancer in Zhejiang Province from 1990 to 2019[J].China Prev Med J,2024,36(3):203-206.(in Chinese)
[19] 叶中文,潘少媚,陈国荣,等.2017—2019年珠海市恶性肿瘤发病及死亡情况分析[J].实用癌症杂志,2025,40(4):686-690.
YE Z W,PAN S M,CHEN G R,et al.Characteristic analysis of malignant tumor incidence and death in Zhuhai,2017-2019[J].Pract J Cancer,2025,40(4):686-690.(in Chinese)
[1] 李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
[2] 胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
[3] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[4] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[5] 朱颖, 郑添. 2013—2023年嘉善县居民期望寿命变化[J]. 预防医学, 2025, 37(6): 598-602.
[6] 董沙沙, 项云飞. 2014—2023年余姚市原发性肝癌死亡与疾病负担分析[J]. 预防医学, 2025, 37(6): 603-607.
[7] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[8] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[9] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[10] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[11] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[12] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[13] 张小乔, 张筱碟, 赵振希, 谢鹏留, 代敏. LSTM、SARIMA和SARIMAX模型预测手足口病发病率的效果比较[J]. 预防医学, 2025, 37(3): 280-284,287.
[14] 沈敏, 郁智慧, 朱爱韬. 1992—2021年中国慢性阻塞性肺疾病发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2025, 37(2): 113-117.
[15] 赵琳, 蒋龙艳, 徐斌, 唐咸艳. 南宁市五种主要恶性肿瘤发病率分析[J]. 预防医学, 2025, 37(2): 135-138.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed